CytomX Therapeutics
CTMX
$1.89
Share price
-5.50%
Change (1 day)
6.78%
Change (1 year)
Categories
CytomX Therapeutics (CTMX) - Net assets
Net assets on the balance sheet as of December 2023 : -$47.45 M
According to CytomX Therapeutics
's latest financial reports the company has -$47.45 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
CytomX Therapeutics - Net assets on balance sheet (from 2014 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $-47.45 M | -44.67% |
| 2022-12-31 | $-85.76 M | 18582.14% |
| 2021-12-31 | $-0.46 M | -94.1% |
| 2020-12-31 | $-7.78 M | -115.21% |
| 2019-12-31 | $51.11 M | -60.95% |
| 2018-12-31 | $0.13 B | 87.25% |
| 2017-12-31 | $69.89 M | -10.94% |
| 2016-12-31 | $78.47 M | -37.75% |
| 2015-12-31 | $0.12 B | -260.51% |
| 2014-12-31 | $-78.55 M | 77.38% |
| 2013-12-31 | $-44.28 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.22 B | -572.29% | 🇺🇸 USA |